Molecular biology of pancreatic cancer
作者： Cristóbal Belda-Iniesta , Inmaculada Ibáñez de Cáceres , Jorge Barriuso , Javier de Castro Carpeño , Manuel González Barón
DOI: 10.1007/S12094-008-0247-6
关键词:
摘要: Pancreatic cancer is a leading cause of death. This devastating disease has the horrible honour close to equal incidence and mortality rates. Late diagnosis constitutive resistance every chemotherapy approach are responsible for this scenario. However, molecular biology tools in cooperation with translational efforts have dissected several secrets that underlie pancreatic cancer. Progressive acquisition malignant, invasive phenotypes from pre-malignant lesions, recent revelations on core signalling pathways new targeted designed trials offer better future patients. review will summarise advances
unirioja.es
springer.com
sci-hub.se 参考文章(64)
Ralph H. Hruban, Scott E. Kern, Michael Goggins, Jennifer Parsons, Progression Model for Pancreatic Cancer Clinical Cancer Research. ,vol. 6, pp. 2969- 2972 ,(2000)
H Teraoka, T Sawada, T Nishihara, M Yashiro, M Ohira, T Ishikawa, H Nishino, K Hirakawa, Enhanced VEGF production and decreased immunogenicity induced by TGF- β 1 promote liver metastasis of pancreatic cancer British Journal of Cancer. ,vol. 85, pp. 612- 617 ,(2001) , 10.1054/BJOC.2001.1941
R H Hruban, C J Yeo, S E Kern, C Caldas, A B Seymour, M S Redston, L da Costa, p53 Mutations in Pancreatic Carcinoma and Evidence of Common Involvement of Homocopolymer Tracts in DNA Microdeletions Cancer Research. ,vol. 54, pp. 3025- 3033 ,(1994)
Yousuke Seo, Hideo Baba, Toshiro Fukuda, Masaki Takashima, Keizo Sugimachi, None, High expression of vascular endothelial growth factor is associated with liver metastasis and a poor prognosis for patients with ductal pancreatic adenocarcinoma Cancer. ,vol. 88, pp. 2239- 2245 ,(2000) , 10.1002/(SICI)1097-0142(20000515)88:10<2239::AID-CNCR6>3.0.CO;2-V
Jeffrey Kreisberg, Shazli Malik, Shujie Zhao, James W Freeman, Daniel DeArmond, Michael G Brattain, John Milburn Jessup, Autocrine-mediated ErbB-2 kinase activation of STAT3 is required for growth factor independence of pancreatic cancer cell lines Oncogene. ,vol. 22, pp. 7781- 7795 ,(2003) , 10.1038/SJ.ONC.1206966
Frank Schönleben, John D. Allendorf, Wanglong Qiu, Xiaojun Li, Daniel J. Ho, Nancy T. Ciau, Robert L. Fine, John A. Chabot, Helen E. Remotti, Gloria H. Su, Mutational analyses of multiple oncogenic pathways in intraductal papillary mucinous neoplasms of the pancreas. Pancreas. ,vol. 36, pp. 168- 172 ,(2008) , 10.1097/MPA.0B013E318158A4D2
Shigeto Ueda, Sho Ogata, Hitoshi Tsuda, Nobuaki Kawarabayashi, Mikihiko Kimura, Yoshiaki Sugiura, Seiichi Tamai, Osamu Matsubara, Kazuo Hatsuse, Hidetaka Mochizuki, The correlation between cytoplasmic overexpression of epidermal growth factor receptor and tumor aggressiveness: poor prognosis in patients with pancreatic ductal adenocarcinoma. Pancreas. ,vol. 29, ,(2004) , 10.1097/00006676-200407000-00061
P. Ghiorzo, L. Pastorino, L. Bonelli, R. Cusano, A. Nicora, S. Zupo, P. Queirolo, M. Sertoli, V. Pugliese, G. Bianchi-Scarrà, INK4/ARF germline alterations in pancreatic cancer patients Annals of Oncology. ,vol. 15, pp. 70- 78 ,(2004) , 10.1093/ANNONC/MDG498
Norishige Yamada, Tomofumi Hamada, Masamichi Goto, Hideaki Tsutsumida, Michiyo Higashi, Mitsuharu Nomoto, Suguru Yonezawa, MUC2 expression is regulated by histone H3 modification and DNA methylation in pancreatic cancer. International Journal of Cancer. ,vol. 119, pp. 1850- 1857 ,(2006) , 10.1002/IJC.22047
Yoshihiro Miyasaka, Eishi Nagai, Hiroshi Yamaguchi, Kei Fujii, Takahiro Inoue, Kenoki Ohuchida, Tomomi Yamada, Kazuhiro Mizumoto, Masao Tanaka, Masazumi Tsuneyoshi, The Role of the DNA Damage Checkpoint Pathway in Intraductal Papillary Mucinous Neoplasms of the Pancreas Clinical Cancer Research. ,vol. 13, pp. 4371- 4377 ,(2007) , 10.1158/1078-0432.CCR-07-0032